The aim of the current study (IDENTIFY) was to gain data on sensitizations toward aeroallergens in patients with severe asthma who had tested negative to perennial aeroallergens in previous tests—i.e., patients being managed in clinical practice as not being indicated anti-IgE therapy for allergic asthma. The gene discussed is IGHE; the disease is allergic asthma.